Ovid Therapeutics Inc. OVID
$2.31
▲ +4.07% 24H
About
Ovid Therapeutics Inc. is a biopharmaceutical company focused on developing small molecule medicines for brain conditions characterized by excess neural excitability, such as rare neurological disorders, epilepsies, and seizure-related issues. The company advances a pipeline targeting neuronal hyperexcitability to rest…
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryUnited States
Employees23
TickerOVID
Statistics
Market Cap$386.4M
Revenue (TTM)$7.3M
Net Income-$17.4M
Net Margin-240.1%
EPS—
P/E-9.61
P/S63.42
P/B2.41
EV/EBITDA-6.42
ROE-18.8%
Dividend Yield—
Price$2.31
Data: Twelve Data · Revenue = mcap / P/S